Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure

  • Chao Chen
  • , Xiang Ni
  • , Shaorui Jia
  • , Yong Liang
  • , Xiaoli Wu
  • , Deling Kong
  • , Dan Ding

Research output: Contribution to journalArticlepeer-review

462 Scopus citations

Abstract

Immunogenic cell death (ICD) provides momentous theoretical principle for modern cancer immunotherapy. However, the currently available ICD inducers are still very limited and photosensitizer-based ones can hardly induce sufficient ICD to achieve satisfactory cancer immunotherapy by themselves. Herein, an organic photosensitizer (named TPE-DPA-TCyP) with a twisted molecular structure, strong aggregation-induced emission activity, and specific ability is reported for effectively inducing focused mitochondrial oxidative stress of cancer cells, which can serve as a much superior ICD inducer to the popularly used ones, including chlorin e6 (Ce6), pheophorbide A, and oxaliplatin. Furthermore, more effective in vivo ICD immunogenicity of TPE-DPA-TCyP than Ce6 is also demonstrated using a prophylactic tumor vaccination model. The underlying mechanism of the effectiveness and robustness of TPE-DPA-TCyP in inducing antitumor immunity and immune-memory effect in vivo is verified by immune cell analyses. This study thus reveals that inducing focused mitochondrial oxidative stress is a highly effective strategy to evoke abundant and large-scale ICD.

Original languageEnglish
Article number1904914
JournalAdvanced Materials
Volume31
Issue number52
DOIs
StatePublished - 1 Dec 2019
Externally publishedYes

Keywords

  • aggregation-induced emission
  • cancer immunotherapy
  • immunogenic cell death inducer
  • mitochondrial targeting
  • photosensitizers

Fingerprint

Dive into the research topics of 'Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure'. Together they form a unique fingerprint.

Cite this